How should healthcare organisations govern privileged vendor access?

Why This Matters for Security Teams

privileged vendor access is one of the easiest ways for healthcare organisations to lose control of critical systems because it often arrives as an exception, not a managed identity. When third-party support accounts are blended into internal admin practices, teams lose clear separation, approval discipline, and revocation certainty. NHIMG’s Ultimate Guide to NHIs notes that 92% of organisations expose NHIs to third parties, which makes vendor access a supply chain issue as much as an identity issue.

Healthcare is especially sensitive because vendor sessions may touch EHRs, imaging systems, lab platforms, identity directories, and remote support tooling. That means a single overbroad account can create both patient-safety risk and audit failure. The right model is temporary, reviewable privilege with explicit session boundaries, not standing trust that persists between support events. Current guidance from NIST Cybersecurity Framework 2.0 and the OWASP Non-Human Identity Top 10 both point toward stronger identity governance, but the operational challenge is making that control usable during urgent clinical support windows. In practice, many security teams discover vendor privilege sprawl only after an incident review or a failed audit, rather than through intentional access design.

How It Works in Practice

Effective governance starts by treating each vendor as a distinct identity class with its own approval workflow, scope, and logging requirements. Vendor access should be brokered through privileged access management, but not simply cloned from internal administrator rights. Instead, access should be granted per session, limited to the named system, and revoked automatically when the support task ends. NHIMG’s Lifecycle Processes for Managing NHIs is a useful reference point for the lifecycle mindset that healthcare teams need here.

Operationally, the control stack usually includes:

• separate vendor accounts and group memberships from internal administrator identities
• time-bound approval for each support session, with a named business owner
• recorded session activity, including commands, file transfers, and configuration changes
• just-in-time privilege elevation only for the exact duration required
• post-session review and automatic credential revocation or expiration

This model works best when identity, logging, and ticketing are linked so reviewers can answer three questions quickly: who accessed what, why was access allowed, and what changed during the session. That is consistent with the broader control themes in the Regulatory and Audit Perspectives section of NHIMG research and with NIST’s emphasis on access accountability. For healthcare environments, the practical goal is not just to record access, but to prove that access was necessary, time-limited, and independently reviewable. These controls tend to break down when vendors share generic support accounts across multiple hospitals because session attribution and revocation become unreliable.

Common Variations and Edge Cases

Tighter vendor control often increases operational friction, requiring organisations to balance patient uptime against the cost of more approvals and shorter access windows. That tradeoff is real in clinical settings where after-hours support, legacy devices, and emergency patching can make ideal workflows difficult. Best practice is evolving, but there is no universal standard for when an emergency override should replace normal vendor approval. The safest approach is to predefine break-glass conditions, require retrospective review, and keep those exceptions rare and documented.

Another common edge case is vendors who need indirect access through managed service consoles or embedded tools. In those cases, the healthcare organisation still owns the trust boundary and should not assume the vendor’s internal controls are sufficient. NHIMG’s Top 10 NHI Issues highlights how excessive privilege and weak lifecycle control routinely turn into exposure. A practical rule is that if the vendor can reach protected clinical systems, the session must be attributable, time-boxed, and inspectable even when the access path is indirect. Where this guidance breaks down most often is in multi-vendor shared maintenance platforms, because overlapping administration paths make it hard to enforce separation of duties cleanly.

Related resources from NHI Mgmt Group

• How should healthcare organisations govern access for non-employees without slowing care delivery?
• How should organisations govern access when digital change outpaces manual reviews?
• How should public sector organisations govern access when staff work remotely?
• How should IAM teams govern access as organisations expand across regions?